2001
DOI: 10.1002/humu.1135
|View full text |Cite
|
Sign up to set email alerts
|

Mutations P51U and G122E in retinal transcription factor NRL associated with autosomal dominant and sporadic retinitis pigmentosa

Abstract: Retinitis pigmentosa (RP) is the most frequent form of inherited retinopathy. RP is genetically heterogeneous with autosomal dominant, autosomal recessive and X-linked forms. Autosomal dominant retinitis pigmentosa (adRP) accounts for about 20-25% of all RP cases. At least ten adRP loci have so far been mapped. However, mutations causing adRP have been identified only in four retina-specific genes: RHO (encoding rhodopsin) in approximately 20% of adRP families, peripherin/RDS (3-5% of adRP) and recently RP1 (P… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
38
1

Year Published

2002
2002
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 40 publications
(40 citation statements)
references
References 16 publications
1
38
1
Order By: Relevance
“…This may, in turn, provide a convenient mechanism for precisely fine-tuning the expression of rhodopsin and other rodspecific genes. This hypothesis is consistent with the human mutation reports; 5 of the 6 mutations of NRL, so far reported in patients with autosomal dominant retinitis pigmentosa, are at residues Ser-50 and Pro-51 (27)(28)(29), and the S50T mutation was shown to enhance the ability of NRL to transactivate the rhodopsin promoter in the presence of CRX (27). In addition, the identification of phosphorylation and subsequent mutation analysis of residue Ser-65 in MafA, the homologous residue of Ser-50 in NRL, further supports this hypothesis (58,59).…”
Section: Discussionsupporting
confidence: 89%
See 1 more Smart Citation
“…This may, in turn, provide a convenient mechanism for precisely fine-tuning the expression of rhodopsin and other rodspecific genes. This hypothesis is consistent with the human mutation reports; 5 of the 6 mutations of NRL, so far reported in patients with autosomal dominant retinitis pigmentosa, are at residues Ser-50 and Pro-51 (27)(28)(29), and the S50T mutation was shown to enhance the ability of NRL to transactivate the rhodopsin promoter in the presence of CRX (27). In addition, the identification of phosphorylation and subsequent mutation analysis of residue Ser-65 in MafA, the homologous residue of Ser-50 in NRL, further supports this hypothesis (58,59).…”
Section: Discussionsupporting
confidence: 89%
“…associated with autosomal dominant retinitis pigmentosa (27)(28)(29). In mice, loss of Nrl results in a complete loss of rods and a concomitant increase in functional S-opsin-expressing cones (30).…”
mentioning
confidence: 99%
“…Subsequent mutation analysis of a large pedigree with autosomal dominant retinitis pigmentosa identified a S50T missense mutation in NRL that cosegregates with the disease (Bessant et al, 1999). Although NRL mutations are rare, additional missense mutations linked to adRP have been identified, with hot spots at residues S50 and P51 (Martinez-Gimeno et al, 2001;DeAngelis et al, 2002;Nishiguchi et al, 2004). Some of these hot spot mutations result in mutant forms of NRL that demonstrate reduced phosphorylation but hyperactivity in activating the rhodopsin promoter with CRX in vitro (Bessant et al, 1999;Nishiguchi et al, 2004;Kanda et al, 2007).…”
Section: Human Genetic Studiesmentioning
confidence: 99%
“…(Akagi, et al, 2004, Brown, et al, 1998, Brown, et al, 2001, Hojo, et al, 2000, Kanekar, et al, 1997, Marquardt and Gruss, 2002, Moore, et al, 2002, Morrow, et al, 1999, Yan and Wang, 1998 Several transcription factors are clearly essential for photoreceptor development, and their mutations cause retinal degenerations: NRL, CRX, Otx2, Trβ2 (thyroid hormone receptor β2), and NR2E3. (Bessant, et al, 1999, DeAngelis, et al, 2002, Freund, et al, 1997, Haider, et al, 2000, Haider, et al, 2001, Martinez-Gimeno, et al, 2001, Ng, et al, 2001, Nishida, et al, 2003, Swain, et al, 1997 However, our knowledge of the interactions of these cell-specific proteins with each other and upstream signal transduction proteins remains sparse. We do not know how this pool of cell-specific transcription factors interacts with the pool of ubiquitous proteins, which include the general transcription machinery and epigenetic regulators of chromatin/DNA structure.…”
Section: Introductionmentioning
confidence: 99%